Companies: 10,795·Total market cap: $144.5T
Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc.

EKSONASDAQHealthcare
$11.80
+$0.15(+1.29%)
Market Cap$28625502
P/E Ratio
52W High$13.5
52W Low$2.73
SEC Filings

Ekso Bionics Holdings, Inc. (EKSO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001549084 · EKSO · NASDAQ · as of Jun 9, 2026

Filing snapshot

682
Total Filings
8-K
Latest Form
2026-06-04
Most Recent
2014
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001549084 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-10
Fiscal Year End
Apr 10, 2026
Accession No.
0001437749-26-012069
Primary Document
ekso20251231_10ka.htm
Source: data.sec.gov · CIK 0001549084 · Accession 0001437749-26-012069

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-04-28
8-KCurrent Report
8-K
2026-06-04Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-04
View
8-K/ACurrent Report (Amended)
8-K/A
2026-05-20
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
3Initial Statement of Beneficial Ownership
3
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-05-12
View
8-K/ACurrent Report (Amended)
8-K/A
2026-05-05
View
8-KCurrent Report
8-K
2026-05-04
View
10-QQuarterly Report
FORM 10-Q
2026-04-28
View
Showing 1–15 of 495 filingsForm 4 / 144 hidden· 682 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001549084  |  Exchange: NASDAQ · Healthcare

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) has submitted 682 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001549084, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ekso Bionics Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Ekso Bionics Holdings, Inc. 10-K was filed on 2026-04-10 for fiscal year ending 2026. Historical EKSO 10-K annual reports are available from 2012 through 2026.

Investors researching Ekso Bionics Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

EKSO SEC Filings · 8 questions

Ekso Bionics Holdings, Inc. (EKSO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 682 filings and access original documents at no cost. Ekso Bionics Holdings, Inc.'s CIK is 0001549084.

EKSO SEC filingsEkso Bionics Holdings, Inc. SEC documentsfind EKSO 10-K